Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
6.83
-0.01 (-0.15%)
At close: Aug 1, 2025, 4:00 PM
6.59
-0.24 (-3.51%)
After-hours: Aug 1, 2025, 6:33 PM EDT
ATSG Market Cap
Solid Biosciences has a market cap or net worth of $529.43 million as of August 1, 2025. Its market cap has increased by 54.82% in one year.
Market Cap
529.43M
Enterprise Value
246.14M
1-Year Change
54.82%
Ranking
Category
Stock Price
$6.83
Market Cap Chart
Since January 26, 2018, Solid Biosciences's market cap has decreased from $7.30B to $529.43M, a decrease of -92.75%. That is a compound annual growth rate of -29.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 529.43M | 231.27% |
| Dec 31, 2024 | 159.82M | 29.00% |
| Dec 29, 2023 | 123.89M | 17.92% |
| Dec 30, 2022 | 105.06M | -45.57% |
| Dec 31, 2021 | 193.02M | -61.33% |
| Dec 31, 2020 | 499.18M | 143.92% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.37B |
| Johnson & Johnson | 402.99B |
| AbbVie | 344.84B |
| AstraZeneca | 228.08B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.54B |
| UnitedHealth Group | 215.69B |
| Novo Nordisk | 211.90B |